Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002312333 | SCV000846407 | likely benign | Inborn genetic diseases | 2016-05-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000956967 | SCV001103759 | benign | Neuronal ceroid lipofuscinosis 13 | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001288579 | SCV001475805 | benign | not specified | 2019-11-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001613439 | SCV001838716 | benign | not provided | 2018-12-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001613439 | SCV005216568 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004731023 | SCV005338083 | benign | CTSF-related disorder | 2024-03-11 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |